Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years
Arthritis Res Ther 2025;27(1):116
Highlighting the importance of early belimumab initiation in SLE, patients with shorter disease duration achieve more substantial improvements in disease activity with early belimumab treatment.
Kojima, et al. provide insights that may help clinicians optimise the timing of belimumab therapy for maximal benefit, this retrospective, observational study of 97 participants with SLE, at Nagasaki University Hospital or its affiliated hospitals in Nagasaki Prefecture, who started treatment with belimumab between December 2017 and August 2021.
Keywords:
